Mobia Medical, Inc. (NASDAQ:MOBI) Stock Short Interest Report for September

Mobia Medical, Inc. (NASDAQ:MOBI) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 1,083,787 shares, a growth of 130.7% from the September 15th total of 469,701 shares. Based on an average daily trading volume, of 381,101 shares, the days-to-cover ratio is presently 2.8 days. Approximately 3.3% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

MOBI has been the subject of a number of recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. BTIG Research restated a “buy” rating and set a $19.00 target price on shares of Mobia Medical in a report on Wednesday, August 12th. Finally, Weiss Ratings began coverage on Mobia Medical in a research report on Wednesday, August 12th. They issued a “sell (e-)” rating for the company. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.75.

Mobia Medical Stock Down 1.6%

Shares of NASDAQ:MOBI opened at $8.36 on Thursday. Mobia Medical has a 52-week low of $8.15 and a 52-week high of $15.29. The stock has a market cap of $278.31 million and a PE ratio of -0.41. The company has a fifty day moving average of $10.45. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04.

Mobia Medical (NASDAQ:MOBI) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The firm had revenue of $13.51 million during the quarter. The company’s revenue was up 102.4% on a year-over-year basis. On average, equities analysts anticipate that Mobia Medical will post -2.63 earnings per share for the current year.

Insider Activity

In other Mobia Medical news, Director Casey Tansey bought 16,441 shares of Mobia Medical stock in a transaction dated Tuesday, August 18th. The stock was acquired at an average cost of $12.07 per share, for a total transaction of $198,442.87. Following the completion of the transaction, the director directly owned 318,332 shares of the company’s stock, valued at approximately $3,842,267.24. This represents a 5.45% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have acquired a total of 87,000 shares of company stock worth $1,016,367 over the last ninety days.

Institutional Investors Weigh In On Mobia Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Readystate Asset Management LP purchased a new position in Mobia Medical during the second quarter worth about $134,000. Citadel Advisors LLC acquired a new position in Mobia Medical in the 2nd quarter valued at about $670,000. Finally, State Street Corp purchased a new stake in shares of Mobia Medical in the 2nd quarter valued at approximately $735,000.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.